• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BCLI

BCLI

Brainstorm Cell Therapeutics Inc.

OTCHealthcareBiotechnologyUS

USD0.77

-0.02 (-2.53%)

Rating:C

Company Profile

CEO

Chaim Lebovits

IPO Date

2003-10-07

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$0.77

Prev. Close

$0.79

Day Low

$0.70

Day High

$0.77

52W Low

$0.46

52W High

$1.33

Market Cap

$0.01B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

41.2%

Avg Negative

2.7%

Avg Neutral

56.1%

News Feed

BrainStorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/5/2021·↓ negative

BrainStorm Increases Commercial Manufacturing Capacity; Granted GMP Certification for a Second Production Site in Israel

PRNewsWire·7/27/2021·↑ positive

BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update

PRNewsWire
·7/26/2021
·↑ positive

Brainstorm Announces Expansion of NurOwn® IP Portfolio with Grant and Allowance of Multiple Patents and Applications in Major Markets

PRNewsWire·6/15/2021·↑ positive

Brainstorm Cell Therapeutics: MSC-NTF Cell Therapy Shows Mid-Stage Promise In PMS

Seeking Alpha·5/30/2021·↑ positive

BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Data at ISCT 2021 New Orleans VIRTUAL Meeting

PRNewsWire·5/25/2021·↑ positive

BrainStorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·4/26/2021·↓ negative

BrainStorm Announces First Quarter 2021 Financial Results and Provides a Corporate Update

PRNewsWire·4/26/2021·↑ positive

BrainStorm to Announce First Quarter Financial Results and Provide a Corporate Update

PRNewsWire·4/19/2021·↑ positive

BCLI Stock Price Increases Over 25% Pre-Market: Why It Happened

Pulse2·3/24/2021·↑ positive